Safety of fecal microbiota transplantation for Clostridioides difficile infection focusing on pathobionts and SARS-CoV-2

Clostridioides difficile infection (CDI) is a consequence of flagrant use of antibiotics, an aging population with increasing comorbidities, and increased hospitalizations. The treatment of choice for CDI is antibiotics (vancomycin or fidaxomicin), with a possibility of recurrent CDI despite lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Devvrat, Khanna, Sahil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064662/
https://www.ncbi.nlm.nih.gov/pubmed/33959193
http://dx.doi.org/10.1177/17562848211009694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064662/
https://www.ncbi.nlm.nih.gov/pubmed/33959193
http://dx.doi.org/10.1177/17562848211009694

Ejemplares similares